Annual report pursuant to Section 13 and 15(d)

Cover Page

v3.24.3
Cover Page - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
May 31, 2024
May 31, 2023
Jul. 31, 2024
Nov. 30, 2023
Cover [Abstract]        
Document Type 10-K/A      
Document Annual Report true      
Document Transition Report false      
Document Period End Date May 31, 2024      
Entity File Number 000-49908      
Entity Registrant Name CytoDyn Inc.      
Entity Incorporation, State or Country Code DE      
Entity Tax Identification Number 83-1887078      
Entity Address, Address Line One 1111 Main Street, Suite 660      
Entity Address, City or Town Vancouver      
Entity Address, State or Province WA      
Entity Address, Postal Zip Code 98660      
City Area Code 360      
Local Phone Number 980-8524      
Title of 12(g) Security Common Stock, par value $0.001 per share      
No Trading Symbol Flag true      
Entity Well-known Seasoned Issuer No      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Small Business true      
Entity Emerging Growth Company false      
Entity Shell Company false      
ICFR Auditor Attestation Flag false      
Entity Common Stock, Shares Outstanding     1,214,900  
Entity Public Float       $ 156,180
Auditor Name Marcum llp Macias Gini & O'Connell LLP    
Auditor Firm ID 688 324    
Auditor Location Hartford, Connecticut San Jose, California    
Current Fiscal Year End Date --05-31      
Document Fiscal Year Focus 2024      
Document Fiscal Period Focus FY      
Entity Central Index Key 0001175680      
Amendment Flag true      
Amendment Description This Amendment No. 1 on Form 10 K/A (this "Form 10 K/A") to the Annual Report on Form 10 K of CytoDyn Inc. for the fiscal year ended May 31, 2024, filed with the Securities and Exchange Commission (the "SEC") on August 15, 2024 (the "Original Form 10-K"), is being filed solely for the purpose of including the information required by Part III of Form 10-K and to correct one exhibit. The Part III information was previously omitted from the Original Form 10 K in reliance on General Instruction G(3) to Form 10-K, which permits the information in the above referenced items to be incorporated in the Form 10 K by reference from our definitive proxy statement if such statement is filed no later than 120 days after our fiscal year-end. We are filing this Amendment No. 1 to include Part III information in our Form 10 K because we will not be filing a definitive proxy statement containing such information within 120 days after the end of the fiscal year covered by the Original Form 10 K. In addition, this Form 10 K/A deletes the reference on the cover page of the Original Form 10 K to the incorporation by reference of portions of our proxy statement into Part III of the Original Form 10 K.Pursuant to Rule 12b 15 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this Form 10 K/A also contains certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, which are filed as exhibits hereto. Because no financial statements have been included in this Form 10-K/A and this Form 10 K/A does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4, and 5 of the certifications have been omitted.Except as described above, this Form 10 K/A does not modify or update disclosure in, or exhibits to, the Original Form 10 K. Further, this Form 10 K/A does not change any previously reported financial results. Information not affected by this Form 10 K/A remains unchanged and reflects the disclosures made at the time the Original Form 10 K was filed.      
Document Financial Statement Error Correction [Flag] false